Ani Pharmaceuticals Sr. VP, General Counsel & Sec. Meredith Cook Sells $35.4K of Stock
Meredith Cook, Sr. VP, General Counsel & Sec., sold 500 shares of Ani Pharmaceuticals Inc at $70.80 a share, worth $35.4K in total on Nov 13, 2026. Shares held after the trade: 72,924 (-0.7%).
Ani Pharmaceuticals SVP & CFO Stephen P. Carey Sells $208K of Stock
Stephen P. Carey, SVP & CFO, sold 2,850 shares of Ani Pharmaceuticals Inc at $72.87 a share, worth $208K in total on Oct 29, 2026. Shares held after the trade: 166,143 (-1.7%).
Ani Pharmaceuticals President & CEO Nikhil Lalwani Sells $388K of Stock
Nikhil Lalwani, President & CEO, sold 5,400 shares of Ani Pharmaceuticals Inc at $71.89 a share, worth $388K in total on Oct 15, 2026. Shares held after the trade: 333,689 (-1.6%).
Ani Pharmaceuticals Sr. VP, General Counsel & Sec. Meredith Cook Sells $36.8K of Stock
Meredith Cook, Sr. VP, General Counsel & Sec., sold 500 shares of Ani Pharmaceuticals Inc at $73.59 a share, worth $36.8K in total on Oct 13, 2026. Shares held after the trade: 73,424 (-0.7%).
Ani Pharmaceuticals SVP & CFO Stephen P. Carey Sells $208K of Stock
Stephen P. Carey, SVP & CFO, sold 2,850 shares of Ani Pharmaceuticals Inc at $73.00 a share, worth $208K in total on Sep 29, 2026. Shares held after the trade: 168,993 (-1.7%).
Ani Pharmaceuticals President & CEO Nikhil Lalwani Sells $383K of Stock
Nikhil Lalwani, President & CEO, sold 5,400 shares of Ani Pharmaceuticals Inc at $71.00 a share, worth $383K in total on Sep 15, 2026. Shares held after the trade: 339,089 (-1.6%).